0001179110-17-006795.txt : 20170508 0001179110-17-006795.hdr.sgml : 20170508 20170508145538 ACCESSION NUMBER: 0001179110-17-006795 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170504 FILED AS OF DATE: 20170508 DATE AS OF CHANGE: 20170508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROPER WILLIAM L CENTRAL INDEX KEY: 0001087960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 17821828 MAIL ADDRESS: STREET 1: 21250 HAWTHORNE BLVD STREET 2: SUITE 800 CITY: TORRANCE STATE: CA ZIP: 90503 4 1 edgar.xml FORM 4 - X0306 4 2017-05-04 0 0000927066 DAVITA INC. DVA 0001087960 ROPER WILLIAM L C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 1 0 0 0 Common Stock 2017-05-04 4 M 0 36000 42.465 A 45277 D Common Stock 2017-05-04 4 F 0 23006 66.45 D 22271 D Common Stock 2017-05-04 4 S 0 12994 65.8879 D 9277 D Stock Appreciation Rights 42.465 2017-05-04 4 M 0 36000 42.465 A 2013-06-11 2017-06-11 Common Stock 36000 0 D Represents the weighted average sale price of $65.8879. The range of prices for the sale of these shares was $65.6600 - $66.2800 rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on 6/11/2012, and vested 100% on 6/11/2013. /s/ Arturo Sida, Attorney-in-Fact 2017-05-08